Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.4K
3.4K
Karyotyping01:17

Karyotyping

12.0K
12.0K
Karyotyping01:17

Karyotyping

70.1K
Overview
70.1K
Tumor Progression02:07

Tumor Progression

7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.

Journal of experimental & clinical cancer research : CR·2026
Same author

A Retrospective Unicenter Study of Clinical and Inflammatory Features in Hospitalized Adults with Respiratory Syncytial Virus Infection Across Two Epidemic Waves in Catalonia, Spain.

Journal of clinical medicine·2026
Same author

The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma.

MedComm·2026
Same author

The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction.

Frontiers in immunology·2026
Same author

Pretreatment MRI: One of the Key Components of Treatment Planning.

Deutsches Arzteblatt international·2026
Same author

Predicting early response to ablative radiotherapy in oligometastatic disease: a scoping review of radiomics-based machine learning and deep learning models.

European radiology·2026
Same journal

Future Challenges of Molecular Imaging in Oncology.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Clinical Applications of Theranostics.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Internal Radiation Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

The Role of Molecular Imaging in Ion Beam Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Molecular Imaging in Photon Radiotherapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Advancements in Intraoperative Imaging for Enhanced Surgical Precision.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

17.7K

Patterns of Chromosomal Aberrations in Solid Tumors.

Marian Grade1, Michael J Difilippantonio2, Jordi Camps3

  • 1University Medical Center Göttingen, Göttingen, Germany.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|September 18, 2015
PubMed
Summary
This summary is machine-generated.

Chromosomal abnormalities, including structural aberrations and copy number alterations, are key to solid tumors. Understanding these genetic changes aids in tumor classification, gene expression analysis, and developing targeted cancer therapies.

Keywords:
Chromosomal aberrationsColorectal cancerCopy number alterationsGene expressionGenomic imbalancesMolecular cytogeneticPloidySolid tumors

More Related Videos

Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

84.5K
Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization mFISH and Spectral Karyotyping SKY in Irradiated Mice
10:14

Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization mFISH and Spectral Karyotyping SKY in Irradiated Mice

Published on: January 11, 2017

10.6K

Related Experiment Videos

Last Updated: Apr 3, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

17.7K
Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

84.5K
Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization mFISH and Spectral Karyotyping SKY in Irradiated Mice
10:14

Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization mFISH and Spectral Karyotyping SKY in Irradiated Mice

Published on: January 11, 2017

10.6K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Chromosomal abnormalities are hallmarks of solid tumors, encompassing structural aberrations and copy number alterations.
  • These alterations lead to aneuploid karyotypes and global transcriptome deregulation in cancer cells.

Purpose of the Study:

  • To explore the role of chromosomal abnormalities in solid tumors.
  • To understand how these genetic changes influence gene expression and tumorigenesis.
  • To highlight the clinical implications of characterizing cytogenetic abnormalities.

Main Methods:

  • Detection and classification of structural chromosomal aberrations.
  • Analysis of copy number alterations and aneuploidies.
  • Correlation of genomic changes with gene expression patterns.

Main Results:

  • Specific tumor entities are associated with distinct chromosomal abnormality patterns.
  • Gross genomic copy number changes globally deregulate cancer cell transcriptomes.
  • Molecular characterization provides insights into tumorigenesis mechanisms.

Conclusions:

  • Chromosomal abnormalities are crucial for defining solid tumors and understanding their molecular basis.
  • Characterization of these genetic alterations facilitates diagnostic and prognostic tool development.
  • Targeted therapies addressing specific genetic abnormalities represent a promising clinical strategy.